| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/14/1995 | EP0656788A1 Hla binding peptides and their uses |
| 06/14/1995 | EP0656787A1 Method of inhibiting reduction of disulfide bonds |
| 06/14/1995 | EP0494260B1 Granulocyte-colony stimulating factor receptors |
| 06/14/1995 | EP0458841B1 Method for the use and synthesis of peptides |
| 06/13/1995 | US5424068 Isolation of low density lipoproteins from blood, fusing them to form heavy microemulsion particles having new antigenic properties, injecting fusion particles back into mammal to remove heavy particles from atherosclerotic lesions |
| 06/13/1995 | US5424067 Water-immiscible oily phase, emulsifying system, and aqueous antigen; nontoxic |
| 06/13/1995 | US5424066 Method for increasing CD4+ cell numbers through the use of monoclonal antibodies directed against self-reactive, CD4 specific cytotoxic T-cells |
| 06/13/1995 | US5424065 Comprising mutant Salmonella |
| 06/13/1995 | CA1339494E Enhancement of the cellular immune response |
| 06/13/1995 | CA1335883C Enhancement of the cellular immune response |
| 06/10/1995 | CA2261433A1 Composition comprising autologous epidermal growth factor |
| 06/08/1995 | WO1995015495A1 Prenatal detection of meconium |
| 06/08/1995 | WO1995015396A1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a |
| 06/08/1995 | WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | WO1995015382A1 Binding structures directed against the ca55.1 antigen |
| 06/08/1995 | WO1995015381A2 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 06/08/1995 | WO1995015373A2 Inhibition of dna methyltransferase |
| 06/08/1995 | WO1995015341A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | WO1995015339A1 Antagonists to chaperonin 10 |
| 06/08/1995 | WO1995015338A1 Chaperonin 10 |
| 06/08/1995 | WO1995015179A1 Method of treating intestinal disorders |
| 06/08/1995 | WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
| 06/08/1995 | WO1995011912A3 Biopolymer synthesis utilizing surface activated, organic polymers |
| 06/08/1995 | WO1995011309A3 A novel nuclear mitotic phosphoprotein: mitosin |
| 06/08/1995 | WO1995002054A3 Platelet glycoprotein v gene and uses |
| 06/08/1995 | WO1994027556A3 Animal model for hepatitis virus infection |
| 06/08/1995 | CA2177991A1 A 46 kd human milk fat globule antigen |
| 06/08/1995 | CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | CA2177584A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | CA2177570A1 Method of treating intestinal disorders |
| 06/08/1995 | CA2177252A1 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer |
| 06/08/1995 | CA2177031A1 Inhibition of dna methyltransferase |
| 06/08/1995 | CA2174972A1 Binding structures directed against the ca55.1 antigen |
| 06/07/1995 | EP0656116A1 Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections |
| 06/07/1995 | EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 06/07/1995 | EP0656069A1 Inhibitors of cell proliferation, their preparation and use |
| 06/07/1995 | EP0656062A1 Dorsal tissue affecting factor and compositions |
| 06/07/1995 | EP0656014A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 06/07/1995 | EP0656013A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 06/07/1995 | EP0656012A1 T cell epitopes of ryegrass pollen allergen |
| 06/07/1995 | EP0656010A1 New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods |
| 06/07/1995 | EP0656007A1 Opioid receptor genes |
| 06/07/1995 | EP0655929A1 Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
| 06/07/1995 | EP0655928A1 Use of an homeopathic product for the manufacture of a medicament for treatment of metabolic diseases |
| 06/07/1995 | EP0655926A1 New tumor diagnosing or therapeutical probe |
| 06/07/1995 | EP0655924A1 A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING |
| 06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
| 06/07/1995 | EP0445128B1 Proteins for fusing the sub-unit b of the choleraic toxin and heterologous antigen, and nucleic acids encoding them |
| 06/07/1995 | CN1103431A Determination of lymph nodes enriched in tumor reactive... |
| 06/07/1995 | CN1103404A Novel monoclonal antibodies recognizing the epidermal growth factor-receptor, cells and methods for producing them and compositions containing them |
| 06/06/1995 | US5422428 Immunization against babesiosis using purified surface antigens of Babesia bigemina and similar immunogens |
| 06/06/1995 | US5422424 Antibiotic cryptdin peptides and methods of their use |
| 06/06/1995 | US5422263 DNA encoding the Trichinella spirals 53kD excretory/secretory antigen for use as immunodiagnostic reagents |
| 06/06/1995 | US5422258 Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils |
| 06/06/1995 | US5422239 Sensitivity; purification of vital antigens |
| 06/06/1995 | US5422110 Enhanced immunogenicity using leukotoxin chimeras |
| 06/06/1995 | US5422109 Fluid vaccines and active principle vehicles containing a metabolizable oil |
| 06/06/1995 | US5421733 Synthesis of Lex ; dimeric Lex (difucosyl Y2 ; III3 FucV3 FucnLc6 Cer); sialylated forms thereof; and analogues thereof |
| 06/06/1995 | CA1335800C Synovial phospholipases |
| 06/06/1995 | CA1335792C Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease |
| 06/06/1995 | CA1335790C Influenza vaccine |
| 06/01/1995 | WO1995014785A1 Composition for the in vivo production of therapeutic products |
| 06/01/1995 | WO1995014781A2 Methods for diagnosing early lyme disease |
| 06/01/1995 | WO1995014778A2 Dna sequence coding for a bmp receptor |
| 06/01/1995 | WO1995014776A1 PROTEIN TYROSINE KINASES NAMED Rse |
| 06/01/1995 | WO1995014713A2 Abundant extracellular products and methods for their production and use |
| 06/01/1995 | WO1995014712A1 Streptococcus pneumoniae hemin/hemoglobin-binding antigens |
| 06/01/1995 | WO1995014493A1 Three-step pretargeting methods and compounds |
| 06/01/1995 | WO1995014487A1 Treatment of viral disease with cd40l peptide |
| 06/01/1995 | WO1995007353A3 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 06/01/1995 | WO1995006732A3 Bacterial exported proteins and acellular vaccines based thereon |
| 06/01/1995 | WO1994026903A3 Human influenza virus peptides binding hla-i molecule |
| 06/01/1995 | WO1994025598A3 Methods and compositions for salmonella-based vaccines |
| 06/01/1995 | WO1994025594A3 Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii |
| 06/01/1995 | CA2177356A1 Methods for diagnosing early lyme disease |
| 06/01/1995 | CA2177037A1 Three-step pretargeting methods and compounds |
| 05/31/1995 | EP0655501A1 HIV-2 virus variants |
| 05/31/1995 | EP0655500A1 Allergenic polypeptide from Japanese cedar pollen and dna encoding it |
| 05/31/1995 | EP0655072A1 Equine herpesvirus glycoproteins |
| 05/31/1995 | EP0557270B1 Cationized antibodies for delivery through the blood-brain barrier |
| 05/31/1995 | EP0372019B1 RHOPTRY MEMBRANE ANTIGEN OF $i(PLASMODIUM FALCIPARUM) |
| 05/31/1995 | CN1102996A Producing process for vaccine of foot and mouth disease |
| 05/30/1995 | US5420264 Non-human primate CD4 polypeptides, human CD4 molecules capable of glycosylation, fragments thereof, fusion proteins thereof, genetic sequences thereof, and the use thereof |
| 05/30/1995 | US5420253 Method for purifying egg yolk immunoglobulins |
| 05/30/1995 | US5420251 Anti-idiotype antibodies specific for the parotope of antibodies which bind to IgE-bearing B cells but not basophils |
| 05/30/1995 | US5420136 Eradication of pathogenic biological contaminants using non-azo naphthalimide dyes |
| 05/30/1995 | US5420030 Molecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereof |
| 05/30/1995 | US5420026 Self-assembling replication defective hybrid virus particles |
| 05/30/1995 | US5419907 Pathogenic porcine respiratory coronavirus |
| 05/30/1995 | US5419904 Human B-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 05/30/1995 | CA1335720C Detection of necrotic malignant tissue and associated therapy |
| 05/26/1995 | WO1995014095A1 Endothelin-converting enzyme |
| 05/26/1995 | WO1995014093A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 05/26/1995 | WO1995014091A2 Compositions and methods for utilizing conditionally lethal genes |
| 05/26/1995 | WO1995014083A1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/26/1995 | WO1995014082A1 Delivery of gene products via mesangial cells |
| 05/26/1995 | WO1995014080A1 Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor |
| 05/26/1995 | WO1995014041A1 Reconstituted human antibody against human medulloblastomatous cell |
| 05/26/1995 | WO1995014026A1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| 05/26/1995 | WO1995013827A1 A method for preventing or controlling cataract |